GILEAD SCIENCES
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
GILEAD SCIENCES
Industry:
Biopharma Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1987-06-22
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.gilead.com
Total Employee:
10001+
Status:
Active
Contact:
650-574-3000
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Aerogen, Inc.
Aerogen, Inc. operates as a specialty pharmaceutical company that develops, manufactures, and commercializes pulmonary.
Apotex Inc.
APOTEX is a pharmaceutical company committed to R&D, affordable medicines to patients.
BTG Specialty Pharmaceuticals
BTG Specialty Pharmaceuticals develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings.
Charles River Laboratories International
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Eli Lilly
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients.
HyperbaricLink
HyperbaricLink is a web guide to hyperbaric oxygen therapy, an FDA-approved medical treatment for specific diseases.
IMA Group
IMA design and manufacture of automatic machines for the processing and packaging of pharmaceuticals.
Ipsen
Ipsen develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products.
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Libertas Pharma
Libertas Pharma a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceutical products.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Meijer
Meijer is a shopping website for grocery, health, and beauty care.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
The Stevanato Group
Stevanato Group S.p.A. manufactures packaging containers from glass tubing for the pharmaceutical industry worldwide.
Vion Pharmaceuticals Inc
Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies.
Zimmer Biomet
Zimmer Biomet designs, develops, manufactures, and markets orthopedic reconstructive and spinal products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-04 | MiroBio | MiroBio acquired by Gilead Sciences | 405 M USD |
| 2020-12-10 | MYR GmbH | MYR GmbH acquired by Gilead Sciences | 1.45 B EUR |
| 2020-09-13 | Immunomedics | Immunomedics acquired by Gilead Sciences | 21 B USD |
| 2020-03-02 | Forty Seven | Forty Seven acquired by Gilead Sciences | 4.9 B USD |
| 2017-12-07 | Cell Design Labs | Cell Design Labs acquired by Gilead Sciences | 567 M USD |
| 2017-08-28 | Kite Pharma | Kite Pharma acquired by Gilead Sciences | 11.9 B USD |
| 2016-04-04 | Nimbus Apollo | Nimbus Apollo acquired by Gilead Sciences | N/A |
| 2015-05-06 | Epitherapeutics | Epitherapeutics acquired by Gilead Sciences | 65 M USD |
| 2015-01-06 | Phenex Pharmaceuticals | Phenex Pharmaceuticals acquired by Gilead Sciences | 470 M USD |
| 2013-02-08 | YM BioSciences | YM BioSciences acquired by Gilead Sciences | 487.6 M USD |
Investors List
Venrock
Venrock investment in Seed Round - Gilead Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | Gilead Sciences investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2022-05-23 | Exavir Therapeutics | Gilead Sciences investment in Seed Round - Exavir Therapeutics | 4 M USD |
| 2022-05-05 | Curebase | Gilead Sciences investment in Series B - Curebase | 40 M USD |
| 2022-01-26 | Kyverna Therapeutics | Gilead Sciences investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2021-12-27 | Pardes Biosciences | Gilead Sciences investment in Post-IPO Equity - Pardes Biosciences | 75 M USD |
| 2021-11-16 | Destination Tomorrow | Gilead Sciences investment in Grant - Destination Tomorrow | 1000 K USD |
| 2021-09-16 | Gritstone Bio | Gilead Sciences investment in Post-IPO Equity - Gritstone Bio | 55 M USD |
| 2021-08-11 | Tango Therapeutics | Gilead Sciences investment in Post-IPO Equity - Tango Therapeutics | 186 M USD |
| 2021-06-24 | Lyndra Therapeutics | Gilead Sciences investment in Series C - Lyndra Therapeutics | 60.5 M USD |
| 2021-03-17 | Vaccitech | Gilead Sciences investment in Series B - Vaccitech | 168 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.gilead.com Semrush global rank: 227.01 K Semrush visits lastest month: 319.31 K
- Host name: 40.70.27.35
- IP address: 40.70.27.35
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917
More informations about "Gilead Sciences"
Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.See details»
Gilead Sciences - The Org
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.See details»
Gilead Sciences, Inc. - Global Health Progress
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and developed innovations in medicine for more than three decades, with the goal of creating better health โฆSee details»
Gilead Sciences, Inc. - Governance - Leadership Team
Leadership Team IR Contact Gilead Investor Relations (650) 574-3000 [email protected]See details»
Gilead Sciences - LinkedIn
Gilead Sciences | 711,873 followers on LinkedIn. Creating Possible | At Gilead, we set โ and achieve โ bold ambitions to create a healthier world for all people. From our pioneering virology ...See details»
Leadership | Gilead
Meet the Gilead Senior Management team and the board of directors and learn more about their roles within Gilead Sciences, Inc.See details»
Gilead Sciences - Wikipedia
Gilead Sciences, Inc. (/ หษกษชliษd /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, โฆSee details»
About Us โ Gilead Life Sciences
We take pride in our state-of-the-art pharmaceutical manufacturing facilities, which are designed to meet the highest global standards of quality, safety, and efficiency. Our production units are โฆSee details»
Gilead Sciences, Inc. -- Company History
Gilead Sciences, Inc. is a biotechnology company specializing in developing and marketing drugs to treat antiviral diseases. Gilead's primary focus is in developing treatments for the human โฆSee details»
Gilead Sciences, Inc. - Investor Relations
Jun 25, 2025 Investor Relations At Gilead, weโre committed to creating a healthier world for everyone โ no matter the challenges ahead of us. For more than 30 years, weโve pursued the impossible, chased it down, tackled it for โฆSee details»
Gilead - Devex
The Gilead Foundation, a non-profit organization established in 2005, seeks to improve the health and well-being of underserved communities around the world.See details»
Creating a - Gilead
At Gilead, we strive to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we deliver innovative therapies that offer new โฆSee details»
Careers at Gilead Sciences
Gilead, a global biopharma co. pursuing innovation in virology, oncology and inflammation, offers a variety of career opportunities in an inclusive workplace where all can make an impact.See details»
Global Operations - gilead.com
This is our global website, intended for visitors seeking information on Gileadโs worldwide business. Some content on this site is not intended for people outside the United States. Visit โฆSee details»
Gilead Sciences, Inc. - Governance - Governance Documents
Governance Documents Commitment to Integrity The ethical standards that govern how Gilead conducts business reflect the company's commitment to integrity and excellence. The โฆSee details»
TIME Names Gilead Sciences as a 2025 Most Influential Company
Jun 26, 2025 TIME recognizes Gilead Sciences on its annual 100 Most Influential Companies list, which highlights companies making an extraordinary impact around the world. "This โฆSee details»
Gilead Sciences, Inc. - Gilead Sciences Announces Fourth Quarter โฆ
Feb 6, 2024 FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2023. โThis was โฆSee details»
Gilead Sciences โ Corporate Responsibility, Leading with Purpose
Gilead goes beyond the medicine, operating as a good corporate citizen that values ethics, health equity, social responsibility & environmental sustainability.See details»
Company | Gilead
At Gilead, we strive to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we deliver innovative therapies that offer new โฆSee details»
Gilead Sciences
More than 18,000 employees at Gilead worldwide work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities โฆSee details»